Actionable news
0
All posts from Actionable news
Actionable news in OTIC: OTONOMY Inc,

Otonomy to Present at the Bank of America Merrill Lynch Healthcare Conference

SAN DIEGO, May 05, 2016 (GLOBE NEWSWIRE via COMTEX) --

Otonomy, Inc. OTIC, -4.26% a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that David A. Weber, Ph.D., president and chief executive officer, will present at the Bank of America Merrill Lynch 2016 Healthcare Conference on Thursday, May 12, 2016 at 10:00 a.m. PT (1:00 p.m. ET) at the Encore at the Wynn Hotel in Las Vegas.

A live audio webcast of the presentation will be available through the Events and Presentations page of the company's website (www.otonomy.com).

About Otonomy

Otonomy is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear. OTIPRIO (ciprofloxacin otic suspension) is approved in the United States for use during tympanostomy tube placement surgery in pediatric patients, and commercial launch commenced in March 2016. OTO-104 is a steroid in development for the treatment of M�ni�re's disease and other severe balance and hearing disorders. Two Phase 3 trials in M�ni�re's disease patients are underway, with results expected during the second half of 2017. OTO-311 is an NMDA receptor antagonist for the treatment of tinnitus that is in a Phase 1 clinical safety trial. Otonomy's proprietary formulation technology utilizes a...


More